Bill Cosby, recently freed from prison, is now the focus of a civil lawsuit in Los Angeles. The case involves one woman who claims he drugged and assaulted her during a 1972 comedy event. She says that after receiving wine and a pill from him, she was unable to recall what happened and woke up disor
Big life insurance firms in Japan are still planning to boost their private loan holdings next year, even though worries about the sector’s health are rising. A recent survey shows that Nippon Life, Meiji Yasuda and Dai‑ichi Life have decided to stick with their current investment strategies. Sumito
Böehme and Scheffler, a lively comedy team known for their circus‑style tricks, have come back to EPCOT’s Germany Pavilion during the Flower and Garden Festival. Guests who visit early in the festival season can catch their short, 15‑minute act inside the pavilion’s gazebo. The show blends qui
Binance has filed a lawsuit against The Wall Street Journal, claiming the paper’s story about the exchange’s handling of $1. 7 billion in illicit transfers is false and damaging. The lawsuit follows a WSJ investigation that said Binance quietly shut down its own probe into the money and let complian
China hit a 5 % growth target in 2025, but the headline numbers hide deeper worries. A housing slump and trade friction with the United States add to a problem that may be harder to solve: young people’s faith in their future. Many millennials and Gen Zers are trading down on everything—from fash
Barbra Streisand will be awarded an honorary Palme d’Or during the 79th Cannes Film Festival in May, marking her debut appearance at the event. The award is a recognition of her long‑standing influence on cinema and popular culture. The ceremony will take place on May 23, the day the festival han
Bam Adebayo’s 83‑point performance against the Washington Wizards turned a regular NBA game into a headline event. The Heat, who were already ahead by 16 points in the fourth quarter, kept Adebayo on the floor to chase a historic total. Coach Erik Spoelstra stayed in the game even as the lead grew,
Bank of America has added Ligand Pharmaceuticals to its list of stocks it recommends buying, setting a new price target at $244. The move comes as the bank highlights Ligand’s business model, which focuses on high‑margin products and a lower level of risk compared to many other biopharma companies.
Circle’s stock has already jumped more than a hundred percent after reporting better-than‑expected earnings, and analysts think it could climb even higher. A brokerage team led by Gautam Chhugani rates the shares as “outperform” and sets a price target of $190, implying a potential rise of about six
Brooks has just lowered the price of its popular Ghost Max L walking shoe, a leather‑finished version of their high‑cushion sneaker. The move makes the shoe more budget‑friendly for people who need sturdy, supportive footwear all day long. The Ghost Max L was originally $170; it now costs $129. 9
